UBS Group »

First Wave Biopharma shares owned by UBS Group

Quarter-by-quarter ownership of First Wave Biopharma (FWBI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in First Wave Biopharma

Tip: Access up to 7 years of quarterly data

All positions including First Wave Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Wave Biopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5k 1.5k 4.20

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding First Wave Biopharma

UBS Group
Wells Fargo & Company
Us Bancorp
Kathleen S. Wright Associates

View all funds holding First Wave Biopharma